BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

398 related articles for article (PubMed ID: 12459621)

  • 1. Renal tumors in the Birt-Hogg-Dubé syndrome.
    Pavlovich CP; Walther MM; Eyler RA; Hewitt SM; Zbar B; Linehan WM; Merino MJ
    Am J Surg Pathol; 2002 Dec; 26(12):1542-52. PubMed ID: 12459621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sporadic hybrid oncocytic/chromophobe tumor of the kidney: a clinicopathologic, histomorphologic, immunohistochemical, ultrastructural, and molecular cytogenetic study of 14 cases.
    Petersson F; Gatalica Z; Grossmann P; Perez Montiel MD; Alvarado Cabrero I; Bulimbasic S; Swatek A; Straka L; Tichy T; Hora M; Kuroda N; Legendre B; Michal M; Hes O
    Virchows Arch; 2010 Apr; 456(4):355-65. PubMed ID: 20300772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Birt-Hogg-Dubé syndrome, a genodermatosis that increases risk for renal carcinoma.
    Schmidt LS
    Curr Mol Med; 2004 Dec; 4(8):877-85. PubMed ID: 15579035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heterozygous germline FLCN mutation in Birt-Hogg-Dubé syndrome with bilateral renal hybrid oncocytic/chromophobe tumor and unilateral renal chromophobe cell carcinoma: a case report.
    Li J; Liu F; Liu X; Hu Y; Liu Z; Shen Y; Wan J
    J Cancer Res Clin Oncol; 2023 Jun; 149(6):2319-2325. PubMed ID: 36258004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The genetics of renal oncocytosis: a possible model for neoplastic progression.
    Al-Saleem T; Cairns P; Dulaimi EA; Feder M; Testa JR; Uzzo RG
    Cancer Genet Cytogenet; 2004 Jul; 152(1):23-8. PubMed ID: 15193438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytologic and histologic findings in multiple renal hybrid oncocytic tumors in a patient with Birt-Hogg-Dubé syndrome: a case report.
    Adley BP; Schafernak KT; Yeldandi AV; Yang XJ; Nayar R
    Acta Cytol; 2006; 50(5):584-8. PubMed ID: 17017453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluorescent and chromogenic in situ hybridization of CEN17q as a potent useful diagnostic marker for Birt-Hogg-Dubé syndrome-associated chromophobe renal cell carcinomas.
    Kato I; Iribe Y; Nagashima Y; Kuroda N; Tanaka R; Nakatani Y; Hasumi H; Yao M; Furuya M
    Hum Pathol; 2016 Jun; 52():74-82. PubMed ID: 26980015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of germline BHD mutation on histological concordance and clinical treatment of patients with bilateral renal masses and known unilateral oncocytoma.
    Boris RS; Benhammou J; Merino M; Pinto PA; Linehan WM; Bratslavsky G
    J Urol; 2011 Jun; 185(6):2050-5. PubMed ID: 21496834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Review of renal oncocytosis (multiple oncocytic lesions) with focus on clinical and pathobiological aspects.
    Kuroda N; Tanaka A; Ohe C; Mikami S; Nagashima Y; Sasaki T; Inoue K; Hes O; Michal M; Brunelli M; Martignoni G
    Histol Histopathol; 2012 Nov; 27(11):1407-12. PubMed ID: 23018240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hybrid chromophobe renal cell neoplasm.
    Mai KT; Dhamanaskar P; Belanger E; Stinson WA
    Pathol Res Pract; 2005; 201(5):385-9. PubMed ID: 16047948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple/bilateral renal tumors in patients with Birt-Hogg-Dubé syndrome.
    Fahmy W; Safwat AS; Bissada NK; Curry N; Guirguis N; Clarke HS; Fraig M; Finkbeiner A
    Int Urol Nephrol; 2007; 39(4):995-9. PubMed ID: 17211573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Birt-Hogg-Dubé syndrome: clinicopathologic findings and genetic alterations.
    Adley BP; Smith ND; Nayar R; Yang XJ
    Arch Pathol Lab Med; 2006 Dec; 130(12):1865-70. PubMed ID: 17149965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical characterization of renal tumors in patients with Birt-Hogg-Dubé syndrome.
    Iribe Y; Kuroda N; Nagashima Y; Yao M; Tanaka R; Gotoda H; Kawakami F; Imamura Y; Nakamura Y; Ando M; Araki A; Matsushima J; Nakatani Y; Furuya M
    Pathol Int; 2015 Mar; 65(3):126-32. PubMed ID: 25597876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Birt-Hogg-Dubé syndrome: a novel marker of kidney neoplasia.
    Toro JR; Glenn G; Duray P; Darling T; Weirich G; Zbar B; Linehan M; Turner ML
    Arch Dermatol; 1999 Oct; 135(10):1195-202. PubMed ID: 10522666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Birt-Hogg-Dubé syndrome in an overall view: Focus on the clinicopathological prospects in renal tumors.
    Wu J; Lu J; Wu CL; Lu M
    Semin Diagn Pathol; 2024 May; 41(3):119-124. PubMed ID: 38242750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of renal and colonic neoplasms and spontaneous pneumothorax in the Birt-Hogg-Dubé syndrome.
    Zbar B; Alvord WG; Glenn G; Turner M; Pavlovich CP; Schmidt L; Walther M; Choyke P; Weirich G; Hewitt SM; Duray P; Gabril F; Greenberg C; Merino MJ; Toro J; Linehan WM
    Cancer Epidemiol Biomarkers Prev; 2002 Apr; 11(4):393-400. PubMed ID: 11927500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Morphological and Molecular Study of Hybrid Oncocytic/Chromophobe Tumor of the Kidney Associated with Sporadic Renal Oncocytosis and Chronic B-Cell Lymphocytic Leukemia: The Possible Contribution of Lymphoma to Renal Oncocytosis.
    Idoate MA; Trigo I; Saenz de Zaitigui J; Pérez-Pérez M; Ríos JJ
    Pathobiology; 2021; 88(4):313-322. PubMed ID: 33882490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal cell tumour characteristics in patients with the Birt-Hogg-Dubé cancer susceptibility syndrome: a retrospective, multicentre study.
    Benusiglio PR; Giraud S; Deveaux S; Méjean A; Correas JM; Joly D; Timsit MO; Ferlicot S; Verkarre V; Abadie C; Chauveau D; Leroux D; Avril MF; Cordier JF; Richard S;
    Orphanet J Rare Dis; 2014 Oct; 9():163. PubMed ID: 25519458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hybrid Oncocytic Tumors (HOTs) in Birt-Hogg-Dubé Syndrome Patients-A Tale of Two Cities: Sequencing Analysis Reveals Dual Lineage Markers Capturing the 2 Cellular Populations of HOT.
    Wang XM; Mannan R; Zhang Y; Chinnaiyan A; Rangaswamy R; Chugh S; Su F; Cao X; Wang R; Skala SL; Hafez KS; Vaishampayan U; Mckenney J; Picken MM; Gupta S; Alaghehbandan R; Tretiakova M; Argani P; Chinnaiyan AM; Dhanasekaran SM; Mehra R
    Am J Surg Pathol; 2024 Feb; 48(2):163-173. PubMed ID: 37994665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Birt-Hogg-Dubé syndrome: novel FLCN frameshift deletion in daughter and father with renal cell carcinomas.
    Näf E; Laubscher D; Hopfer H; Streit M; Matyas G
    Fam Cancer; 2016 Jan; 15(1):127-32. PubMed ID: 26342594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.